glp 1 insulin combo GIP/GLP-1 Injectable Beats for A1c Reduction If You Are Taking a

OXM, Oxyntomodulin

Originally approved for type 2 diabetes and later for obesity treatment, GLP-1 and other incretin-based therapies have rapidly gained traction in both clinical and consumer spaces

Theoretically, increasing GLP-1 before a meal may decrease appetite and the amount eaten

Indeed, surgical procedures that modulate gastric anatomy or function, including gastrectomy, RYGB, VSG or Billroth II (partial gastrectomy and intestinal rearrangement), increase 18 F-fluorodeoxyglucose uptake in multiple intestinal segments in humans 23,24 and rats 22 in correlation with reduced fasting blood levels of glucose

Gordon ER, Musleh S, Bordone LA

95% CI, 1.23-1.74)